| Product NDC: | 55390-123 |
| Proprietary Name: | Rifampin |
| Non Proprietary Name: | Rifampin |
| Active Ingredient(s): | 600 mg/10mL & nbsp; Rifampin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55390-123 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA064217 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20020218 |
| Package NDC: | 55390-123-01 |
| Package Description: | 1 VIAL in 1 BOX, UNIT-DOSE (55390-123-01) > 10 mL in 1 VIAL |
| NDC Code | 55390-123-01 |
| Proprietary Name | Rifampin |
| Package Description | 1 VIAL in 1 BOX, UNIT-DOSE (55390-123-01) > 10 mL in 1 VIAL |
| Product NDC | 55390-123 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Rifampin |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20020218 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | RIFAMPIN |
| Strength Number | 600 |
| Strength Unit | mg/10mL |
| Pharmaceutical Classes | Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient] |